| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,873 |
1,870 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
5,260 |
4,274 |
$4K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
573 |
572 |
$3K |
| 99386 |
|
249 |
249 |
$2K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
37 |
32 |
$2K |
| 99385 |
|
67 |
67 |
$1K |
| 3078F |
|
2,405 |
1,975 |
$572.50 |
| 3074F |
|
2,393 |
1,930 |
$510.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
105 |
105 |
$303.87 |
| 97802 |
|
1,329 |
1,327 |
$252.13 |
| 36415 |
Collection of venous blood by venipuncture |
3,688 |
3,442 |
$145.68 |
| 1159F |
|
3,956 |
2,989 |
$124.20 |
| 1160F |
|
4,018 |
3,028 |
$124.20 |
| 3075F |
|
370 |
343 |
$47.50 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
35 |
34 |
$40.12 |
| 2028F |
|
893 |
893 |
$4.20 |
| 3725F |
|
952 |
950 |
$4.20 |
| 3016F |
|
895 |
894 |
$4.20 |
| 1036F |
|
817 |
817 |
$4.20 |
| 1000F |
|
887 |
886 |
$4.20 |
| 2000F |
|
3,789 |
2,953 |
$4.20 |
| 2010F |
|
3,663 |
2,857 |
$4.20 |
| H0001 |
Alcohol and/or drug assessment |
1,816 |
1,814 |
$4.20 |
| 2001F |
|
3,660 |
2,854 |
$4.20 |
| 94760 |
|
1,296 |
1,295 |
$3.12 |
| G9383 |
Patient received screening for hcv infection within the 12 month reporting period |
629 |
622 |
$0.00 |
| G9820 |
Documentation of a chlamydia screening test with proper follow-up |
572 |
570 |
$0.00 |
| 99072 |
|
1,827 |
1,332 |
$0.00 |
| G9622 |
Patient not identified as an unhealthy alcohol user when screened for unhealthy alcohol use using a systematic screening method |
1,615 |
1,614 |
$0.00 |
| 3050F |
|
111 |
109 |
$0.00 |
| 3077F |
|
126 |
115 |
$0.00 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
17 |
16 |
$0.00 |
| 3015F |
|
208 |
197 |
$0.00 |
| G0270 |
Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes |
12 |
12 |
$0.00 |
| 4293F |
|
687 |
686 |
$0.00 |
| 3008F |
|
1,302 |
1,086 |
$0.00 |
| 3044F |
|
913 |
903 |
$0.00 |
| 3048F |
|
351 |
347 |
$0.00 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
545 |
542 |
$0.00 |
| 3017F |
|
379 |
344 |
$0.00 |
| 2023F |
|
50 |
48 |
$0.00 |
| 3079F |
|
534 |
477 |
$0.00 |
| 3011F |
|
956 |
945 |
$0.00 |
| 3014F |
|
111 |
106 |
$0.00 |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
1,272 |
1,271 |
$0.00 |
| 3061F |
|
941 |
921 |
$0.00 |
| 3080F |
|
29 |
27 |
$0.00 |
| 3049F |
|
129 |
128 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18 |
17 |
$0.00 |